{"id":"NCT00718120","sponsor":"GlaxoSmithKline","briefTitle":"Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years","officialTitle":"Immunogenicity and Safety Study of a Single Injection of GSK Biologicals' Trivalent Split Virion Influenza Vaccine Fluviral® (2008 - 2009 Season) in Adults Aged 18 to 60 Years and Over 60 Years.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-07-18","primaryCompletion":"2008-08-09","completion":"2008-08-09","firstPosted":"2008-07-18","resultsPosted":"2009-08-25","lastUpdate":"2019-06-26"},"enrollment":110,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Influenza Vaccines"],"interventions":[{"type":"BIOLOGICAL","name":"Fluviral®","otherNames":[]}],"arms":[{"label":"Fluviral Adult Group","type":"EXPERIMENTAL"},{"label":"Fluviral Elderly Group","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the immunogenicity and safety of GSK Biologicals' Trivalent split virion influenza vaccine Fluviral for the 2008-2009 season in adults over the age of 18.","primaryOutcome":{"measure":"Hemagglutination Inhibition (HI) Antibody Titers","timeFrame":"At Day 0 and 21","effectByArm":[{"arm":"Fluviral Adult Group","deltaMin":19.5,"sd":null},{"arm":"Fluviral Elderly Group","deltaMin":13.9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":22},"locations":{"siteCount":1,"countries":["Canada"]},"refs":{"pmids":[],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":55},"commonTop":["Pain at the injection site","Muscle aches","Headache","Fatigue","Joint pain at other location"]}}